These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2657284)

  • 41. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; problems on standardization of the appropriate time for the withdrawal of anti-ulcer agents].
    Takemoto T; Yanai H
    Nihon Rinsho; 1988 Jan; 46(1):133-9. PubMed ID: 3373746
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinico-pathogenetic aspects of peptic ulcer therapy].
    Chernin VV
    Ter Arkh; 1991; 63(2):124-7. PubMed ID: 2048004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microbes, peptic ulcer, and relapse rates with different drugs.
    McLean AJ; Harrison PM; Ioannides-Demos LL; Byrne AJ; McCarthy P; Dudley FJ
    Lancet; 1984 Sep; 2(8401):525-6. PubMed ID: 6147588
    [No Abstract]   [Full Text] [Related]  

  • 44. Relapse rate as a major determinant of drug selection in peptic ulcer therapy.
    McLean AJ; Harcourt DM; McNeil JJ
    Drugs; 1988 Apr; 35(4):329-33. PubMed ID: 3292207
    [No Abstract]   [Full Text] [Related]  

  • 45. Maintenance therapy for prevention of recurrent peptic ulcers.
    Berardi RR; Savitsky ME; Nostrant TT
    Drug Intell Clin Pharm; 1987 Jun; 21(6):493-501. PubMed ID: 3301245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [H2 receptor antagonists in the therapy of peptic ulcer disease].
    Dammann HG; Dau B; Dreyer M; Müller P; Simon B
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():136-45. PubMed ID: 2889298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic approach to peptic ulcer relapse.
    Rodrigo JM; Ponce J
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():131-5. PubMed ID: 2657284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic failure and relapse in peptic ulcer.
    Ponce J; Rodrigo JM
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():123-30. PubMed ID: 2657282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of protective drugs in the prevention of ulcer relapse.
    Ota S; Terano A
    J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G; Hopkins A; Akbar FA
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.